CA1075228A - Flunisolide to treat respiratory diseases - Google Patents
Flunisolide to treat respiratory diseasesInfo
- Publication number
- CA1075228A CA1075228A CA253,267A CA253267A CA1075228A CA 1075228 A CA1075228 A CA 1075228A CA 253267 A CA253267 A CA 253267A CA 1075228 A CA1075228 A CA 1075228A
- Authority
- CA
- Canada
- Prior art keywords
- prepared
- microns
- flunisolide
- process according
- particle size
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA332,220A CA1083963A (en) | 1975-05-27 | 1979-07-20 | Use of flunisolide to treat respiratory diseases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58130075A | 1975-05-27 | 1975-05-27 | |
US58130175A | 1975-05-27 | 1975-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1075228A true CA1075228A (en) | 1980-04-08 |
Family
ID=27078279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA253,267A Expired CA1075228A (en) | 1975-05-27 | 1976-05-25 | Flunisolide to treat respiratory diseases |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS51144719A (de) |
AT (1) | AT357702B (de) |
AU (1) | AU506080B2 (de) |
CA (1) | CA1075228A (de) |
DE (2) | DE2624924C2 (de) |
ES (1) | ES448220A1 (de) |
FR (1) | FR2361900A1 (de) |
GB (1) | GB1525181A (de) |
HK (1) | HK8580A (de) |
IL (1) | IL49652A (de) |
MX (1) | MX3864E (de) |
MY (1) | MY8000275A (de) |
NL (1) | NL191234C (de) |
NZ (1) | NZ180946A (de) |
SE (1) | SE421426B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55154997A (en) * | 1979-05-21 | 1980-12-02 | Syntex Corp | Manufacture of flunisolide having peculiar crystal form |
EP0039369B1 (de) * | 1980-05-02 | 1983-06-15 | Schering Corporation | Beclomethason-ester-solvate, Verfahren zu ihrer Herstellung und Herstellung einer Formulierung |
GB2127689B (en) * | 1982-10-05 | 1986-07-09 | Sandoz Ltd | Calcitonin inhalation compositions |
US4782047A (en) * | 1986-05-22 | 1988-11-01 | Syntex Pharmaceuticals International Ltd. | Aqueous steroid formulations for nasal administration |
US5707634A (en) * | 1988-10-05 | 1998-01-13 | Pharmacia & Upjohn Company | Finely divided solid crystalline powders via precipitation into an anti-solvent |
AU624421B2 (en) * | 1988-10-05 | 1992-06-11 | Pharmacia & Upjohn Company | Finely divided solid crystalline powders via precipitation into an anti-solvent |
DE4003272A1 (de) | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen |
AU721566B2 (en) * | 1995-06-27 | 2000-07-06 | Boehringer Ingelheim Kg | New stable pharmaceutical preparation for producing propellant-free aerosols |
DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
ME00220B (me) | 2000-05-22 | 2010-10-10 | Chiesi Farm Spa | Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom |
TR200401980T4 (tr) | 2001-07-02 | 2004-09-21 | Chiesi Farmaceutici S.P.A. | Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu |
JP4632687B2 (ja) * | 2003-04-25 | 2011-02-16 | ロート製薬株式会社 | 点鼻剤 |
JP5238779B2 (ja) * | 2003-04-25 | 2013-07-17 | ロート製薬株式会社 | 点鼻剤 |
EP1595531A1 (de) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stabile Arzneimittellösung für Druckdosierinhalatoren |
AU2014233362A1 (en) * | 2013-03-15 | 2015-10-01 | Medicis Pharmaceutical Corporation | Topical compositions of flunisolide and methods of treatment |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3126375A (en) * | 1964-03-24 | Chioacyl | ||
GB933868A (en) * | 1958-12-08 | 1963-08-14 | American Cyanamid Co | Process for fluorinating steroids |
US3282791A (en) * | 1965-08-17 | 1966-11-01 | Merck & Co Inc | Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate |
US3592930A (en) * | 1968-07-19 | 1971-07-13 | Syntex Corp | Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle |
FR2038105A1 (fr) * | 1969-04-01 | 1971-01-08 | Syntex Corp | Composition anti-inflammatoire locale et son mode d'utilisation |
GB1429184A (en) * | 1972-04-20 | 1976-03-24 | Allen & Hanburys Ltd | Physically anti-inflammatory steroids for use in aerosols |
DE2332663C2 (de) * | 1973-06-23 | 1986-07-31 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie |
US3934013A (en) | 1975-02-21 | 1976-01-20 | Syntex (U.S.A.) Inc. | Pharmaceutical composition |
-
1976
- 1976-05-14 MX MX76234U patent/MX3864E/es unknown
- 1976-05-25 SE SE7605927A patent/SE421426B/xx not_active IP Right Cessation
- 1976-05-25 IL IL49652A patent/IL49652A/xx unknown
- 1976-05-25 ES ES448220A patent/ES448220A1/es not_active Expired
- 1976-05-25 NZ NZ180946A patent/NZ180946A/xx unknown
- 1976-05-25 CA CA253,267A patent/CA1075228A/en not_active Expired
- 1976-05-26 GB GB21936/76A patent/GB1525181A/en not_active Expired
- 1976-05-26 JP JP51061032A patent/JPS51144719A/ja active Granted
- 1976-05-26 AU AU14301/76A patent/AU506080B2/en not_active Expired
- 1976-05-26 FR FR7616040A patent/FR2361900A1/fr active Granted
- 1976-05-26 AT AT388376A patent/AT357702B/de not_active IP Right Cessation
- 1976-05-26 NL NL7605699A patent/NL191234C/xx not_active IP Right Cessation
- 1976-06-03 DE DE2624924A patent/DE2624924C2/de not_active Expired
- 1976-06-03 DE DE2661037A patent/DE2661037C2/de not_active Expired
-
1980
- 1980-03-06 HK HK85/80A patent/HK8580A/xx unknown
- 1980-12-30 MY MY275/80A patent/MY8000275A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ES448220A1 (es) | 1977-11-01 |
IL49652A (en) | 1979-05-31 |
AT357702B (de) | 1980-07-25 |
JPS6247880B2 (de) | 1987-10-09 |
FR2361900A1 (fr) | 1978-03-17 |
IL49652A0 (en) | 1976-07-30 |
MY8000275A (en) | 1980-12-31 |
AU1430176A (en) | 1977-12-01 |
NZ180946A (en) | 1978-07-28 |
NL191234B (nl) | 1994-11-01 |
SE7605927L (sv) | 1976-11-28 |
NL7605699A (nl) | 1976-11-30 |
MX3864E (es) | 1981-08-26 |
AU506080B2 (en) | 1979-12-13 |
DE2624924A1 (de) | 1977-12-15 |
DE2624924C2 (de) | 1986-11-27 |
DE2661037C2 (de) | 1989-04-06 |
FR2361900B1 (de) | 1979-04-13 |
NL191234C (nl) | 1995-04-03 |
SE421426B (sv) | 1981-12-21 |
JPS51144719A (en) | 1976-12-13 |
HK8580A (en) | 1980-03-14 |
ATA388376A (de) | 1979-12-15 |
GB1525181A (en) | 1978-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1075228A (en) | Flunisolide to treat respiratory diseases | |
KR890000664B1 (ko) | 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법 | |
US4364923A (en) | Chemical compounds | |
EP1102579B1 (de) | Medizinische aerosolformulierungen | |
RU2294737C2 (ru) | Медицинские аэрозольные составы | |
US5292499A (en) | Method of preparing medical aerosol formulations including drug dissolved in reverse micelles | |
EP0806940B1 (de) | Aerosol-arzneiformulierungen | |
US5118494A (en) | Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations | |
US4044126A (en) | Steroidal aerosol compositions and process for the preparation thereof | |
US4352789A (en) | Aerosol compositions containing finely divided solid materials | |
EP1014943B1 (de) | Medizinische aerosolformulierungen | |
CA1253806A (en) | Physically modified beclomethasone dipropionate suitable for use in aerosols | |
EP1100465A1 (de) | Medizinische aerosolformulierungen | |
DE2703119C2 (de) | ||
EP1572153B1 (de) | Herstellung von sterilen wässrigen suspensionen mit mikronisierten kristallinen wirkstoffen zur inhalation | |
EP0039369A1 (de) | Beclomethason-ester-solvate, Verfahren zu ihrer Herstellung und Herstellung einer Formulierung | |
JP2004515454A (ja) | 気管支肺疾患の治療のためのグルココルチコイド薬物を含有する製剤 | |
US4933168A (en) | Stable, crystalline flunisolide | |
PT927037E (pt) | Formulacoes em aerossol de furoato de mometasona sem clorofluorocarbonetos | |
US4225597A (en) | Beclomethasone dipropionate-hexane solvate and aerosols prepared therefrom | |
CA1083963A (en) | Use of flunisolide to treat respiratory diseases | |
JPS62281817A (ja) | 鼻用噴霧液 | |
DE2831419A1 (de) | Dispersion oder suspension aus lecithin oder einem sorbitan- oder sorbit-ester in treibmittel 12 | |
KR0175164B1 (ko) | 에어로졸 약물 제제 | |
MXPA99011675A (en) | Proliposome powders for inhalation stabilised by tocopherol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |